Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001036666 | SCV001200042 | likely pathogenic | Mucopolysaccharidosis, MPS-IV-B; GM1 gangliosidosis | 2024-02-13 | criteria provided, single submitter | clinical testing | This variant, c.1468_1470del, results in the deletion of 1 amino acid(s) of the GLB1 protein (p.Asn490del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has been observed in individual(s) with clinical features of GLB1-related conditions (PMID: 26646981, 30187681; Invitae). ClinVar contains an entry for this variant (Variation ID: 835718). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Gene |
RCV003329368 | SCV004036719 | likely pathogenic | not provided | 2023-03-23 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30187681, 26646981) |